02 August 2018
Visiongain has launched a new pharma report Global Healthcare Biometrics Market Forecast 2018-2028: Patient Identification & Tracking, Care Provider Authentication, Medical Record Security & Data Centre Security, Remote Patient Monitoring, Pharmacy Dispensing, Face Recognition, Finger Recognition, Iris Recognition, Vein Recognition, Palm Geometry Recognition, Behavioural Recognition, Hospitals & Clinics, Research & Clinical Laboratory
The biometric technologies including fingerprint recognition, vein recognition, iris recognition, and face recognition are gaining popularity in healthcare sector. The rise in popularity is due to its wide range of applications for health-care provider authentication, patient identification and tracking, medical record security, and data centre security. The growing demand for these biometrics solutions is primarily driven by the need to improve patient confidentiality, and healthcare safety.
In the recent past there has been an increase in the adoption of biometric in the healthcare industry. This integration majorly refers to patient identification and staff authentication. Healthcare industry in the United States is one of the most lucrative industries globally with over 17.9 percent of its Gross Domestic Product being spent on healthcare. According to World Health Organization, U.S. healthcare spending reached USD 2.9 trillion in the year 2013. These facts are indicative of the immense burden healthcare providers’ face on a daily basis to treat patients with a wide range of disorders.
‘’Global healthcare biometrics market is growing rapidly, this is primarily due to increasing awareness about safety and security of patients, increasing application of biometrics devices in healthcare sector application and other data and growing healthcare infrastructure. North America accounts for largest market for healthcare biometrics devices while Asia-Pacific is fastest growing market. Global healthcare biometrics market is expected to grow to $5.02 billion by 2023.’’ – Pharmaceutical Industry Analyst
Leading companies featured in the report include Fujitsi Limited, 3M Congent, Inc.,NEC Corporation, Safran Identity & Security SAS (Morpho), Bio-Key International, Inc., Assa Abloy Group, Imprivata, Inc., Suprema, Inc, Crossmatch Technologies, Inc., Zkteco, Inc.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 207 336 6100
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
. The growth of this market is majorly driven by increasing sales of temperature sensitive pharmaceutical products, longer life expectancy and rising geriatric population are some of the prominent factors.
16 September 2020
Visiongain forecasts a continuing growth in global market, submarket and product sales as human vaccines drive pharmaceutical business sales. New key players and technological progress will enter the industry, leading to an increase in the market size of the world market for human vaccines in general.
14 September 2020
The global ophthalmic ultrasound systems market is driven by factors such as the increasing prevalence of ocular disorders and diseases, adoption of novel ophthalmic technologies, rising focus on research & development, and growing health awareness amongst the population.
09 September 2020
The current COVID-19 pandemic is anticipated to have a minor impact on the overall outsourcing business outlook for global drug discovery. Also, significant growth during the COVID-19 pandemic is expected to be seen in the outsourcing of drugs and medicines needed to treat COVID-19 infections.